col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

American Diabetes Association: Diabetes Care
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―14 Primary Care Health Care Use for Patients With Type 2 Diabetes During the COVID-19 Pandemic Anita D. Misra-Hebert, Bo Hu, Kevin M. Pantalone, Elizabeth R. Pfoh
2 [GO] 2021―Jul―12 Atherogenic Dyslipidemia on Admission Is Associated With Poorer Outcome in People With and Without Diabetes Hospitalized for COVID-19 Alfonso Bellia, Aikaterini Andreadi, Luca Giudice, Sofia De Taddeo, Alessio Maiorino, Ilenia D'Ippolito, et al. (+7)
3 [GO] 2021―Jul―09 Diabetes and COVID-19: Population Impact 18 Months Into the Pandemic Edward W. Gregg, Marisa K. Sophiea, Misghina Weldegiorgis
4 [GO] 2021―Jul―08 Diabetes, Obesity, COVID-19, Insulin, and Other Antidiabetes Drugs Paresh Dandona, Husam Ghanim
5 [GO] 2021―Jul―07 Excess Mortality in COVID-19-Positive Versus COVID-19-Negative Inpatients With Diabetes: A Nationwide Study Elias K. Spanakis, Ashley Yoo, Oluwagbemiga N. Ajayi, Tariq Siddiqui, Mohd M. Khan, Stephen L. Seliger, et al. (+3)
6 [GO] 2021―Jun―26 COVID-19 and Type 1 Diabetes: Addressing Concerns and Maintaining Control Linda A. DiMeglio
7 [GO] 2021―Jun―22 Intensive Care Unit Admission, Mechanical Ventilation, and Mortality Among Patients With Type 1 Diabetes Hospitalized for COVID-19 in the U.S. Catherine E. Barrett, Joohyun Park, Lyudmyla Kompaniyets, James Baggs, Yiling J. Cheng, Ping Zhang, et al. (+2)
8 [GO] 2021―Jun―22 Impact of COVID-19 on Diabetes Health Care and Service Provision in Australian Diabetes Centers Matthew Quigley, Arul Earnest, Naomi Szwarcbard, Natalie Wischer, Sophia Zoungas
9 [GO] 2021―Jun―18 Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry Nudrat Noor, Osagie Ebekozien, Laura Levin, Sheri Stone, David P. Sparling, Robert Rapaport, David M. Maahs
10 [GO] 2021―Jun―16 Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes Anna R. Kahkoska, Trine Julie Abrahamsen, G. Caleb Alexander, Tellen D. Bennett, Christopher G. Chute, Melissa A. Haendel, et al. (+7)
11 [GO] 2021―Jun―16 Increase in Diabetes Mortality Associated With COVID-19 Pandemic in the U.S. Jinjun Ran, Shi Zhao, Lefei Han, Yang Ge, Marc K.C. Chong, Wangnan Cao, Shengzhi Sun
12 [GO] 2021―May―20 Temporal Trends in Lower-Limb Major and Minor Amputation and Revascularization Procedures in People With Diabetes in England During the COVID-19 Pandemic Jonathan Valabhji, Emma Barron, Eszter P. Vamos, Ketan Dhatariya, Frances Game, Partha Kar, et al. (+4)
13 [GO] 2021―May―14 Frequency of Autoantibody-Negative Type 1 Diabetes in Children, Adolescents, and Young Adults During the First Wave of the COVID-19 Pandemic in Germany Clemens Kamrath, Joachim Rosenbauer, Sascha R. Tittel, Katharina Warncke, Raphael Hirtz, Christian Denzer, et al. (+4)
14 [GO] 2021―May―10 Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532 David M. Maahs, G. Todd Alonso, Mary Pat Gallagher, Osagie Ebekozien
15 [GO] 2021―May―10 Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532 Justin M. Gregory, James C. Slaughter, Sara H. Duffus, T. Jordan Smith, Lauren M. LeStourgeon, Sarah S. Jaser, et al. (+6)
16 [GO] 2021―Apr―26 Spike in Diabetic Ketoacidosis Rates in Pediatric Type 2 Diabetes During the COVID-19 Pandemic Lily C. Chao, Alaina P. Vidmar, Senta Georgia
17 [GO] 2021―Apr―15 Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis Danielle K. Longmore, Jessica E. Miller, Siroon Bekkering, Christoph Saner, Edin Mifsud, Yanshan Zhu, et al. (+5)
18 [GO] 2021―Apr―13 The Rapid Transition to Telemedicine and Its Effect on Access to Care for Patients With Type 1 Diabetes During the COVID-19 Pandemic Daniel R. Tilden, Karishma A. Datye, Daniel J. Moore, Benjamin French, Sarah S. Jaser
19 [GO] 2021―Feb―11 Thresholds of Glycemia and the Outcomes of COVID-19 Complicated With Diabetes: A Retrospective Exploratory Study Using Continuous Glucose Monitoring Yun Shen, Xiaohong Fan, Lei Zhang, Yaxin Wang, Cheng Li, Jingyi Lu, et al. (+5)
20 [GO] 2021―Feb―10 Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept Georgia M. Davis, Eileen Faulds, Tara Walker, Debbie Vigliotti, Marina Rabinovich, Joi Hester, et al. (+12)
21 [GO] 2021―Feb―05 Association Between DPP-4 Inhibitors and COVID-19 Related Outcomes Among Patients With Type 2 Diabetes Yunha Noh, In-Sun Oh, Han Eol Jeong, Kristian B. Filion, Oriana Hoi Yun Yu, Ju-Young Shin
22 [GO] 2021―Jan―21 Association of Early-Phase In-Hospital Glycemic Fluctuation With Mortality in Adult Patients With Coronavirus Disease 2019 Liangkai Chen, Wenwu Sun, Yanli Liu, Lijuan Zhang, Yanling Lv, Qiang Wang, et al. (+6)
23 [GO] 2020―Dec―23 Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic Shivani Agarwal, Justin Mathew, Georgia M. Davis, Alethea Shephardson, Ann Levine, Rita Louard, et al. (+5)
24 [GO] 2020―Dec―23 Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes Louis Potier, Boris Hansel, Etienne Larger, Jean-François Gautier, Daphné Carreira, Rachel Assemien, et al. (+3)
25 [GO] 2020―Dec―22 A Lesson From 2020: Public Health Matters for Both COVID-19 and Diabetes Matthew C. Riddle, George Bakris, Lawrence Blonde, Andrew J.M. Boulton, David D’Alessio, Linda A. DiMeglio, et al. (+10)
26 [GO] 2020―Dec―22 Comparison of Diabetic Ketoacidosis in Adults During the SARS-CoV-2 Outbreak and Over the Same Time Period for the Preceding 3 Years Shivani Misra, Baktash Khozoee, Jiawei Huang, Kyriaki Mitsaki, Monika Reddy, Victoria Salem, et al. (+5)
27 [GO] 2020―Dec―16 Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis David C. Klonoff, Jordan C. Messler, Guillermo E. Umpierrez, Limin Peng, Robby Booth, Jennifer Crowe, et al. (+3)
28 [GO] 2020―Dec―09 Diabetes and COVID-19-Related Mortality in Women and Men in the UK Biobank: Comparisons With Influenza/Pneumonia and Coronary Heart Disease Marit de Jong, Mark Woodward, Sanne A.E. Peters
29 [GO] 2020―Dec―07 Diabetic Foot Care Before and During the COVID-19 Epidemic: What Really Matters? Vilma Urbančič-Rovan
30 [GO] 2020―Dec―03 COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes Justin M. Gregory, James C. Slaughter, Sara H. Duffus, T. Jordan Smith, Lauren M. LeStourgeon, Sarah S. Jaser, et al. (+6)
31 [GO] 2020―Nov―19 Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages Sandra G. Sosa-Rubí, Jacqueline A. Seiglie, Carlos Chivardi, Jennifer Manne-Goehler, James B. Meigs, Deborah J. Wexler, et al. (+3)
32 [GO] 2020―Nov―02 Racial and Geographic Disparities in Internet Use in the U.S. Among Patients With Hypertension or Diabetes: Implications for Telehealth in the Era of Coronavirus Disease 2019 Vardhmaan Jain, Mahmoud Al Rifai, Michelle T. Lee, Ankur Kalra, Laura A. Petersen, Elizabeth M. Vaughan, et al. (+3)
33 [GO] 2020―Oct―30 The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care. Analysis from an outbreak area in North-East Italy Benedetta Maria Bonora, Mario Luca Morieri, Angelo Avogaro, Gian Paolo Fadini
34 [GO] 2020―Oct―23 Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020 John M. Dennis, Bilal A. Mateen, Raphael Sonabend, Nicholas J. Thomas, Kashyap A. Patel, Andrew T. Hattersley, et al. (+3)
35 [GO] 2020―Oct―20 Comment on McIntyre and Moses The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic. Diabetes Care 2020;43:1433-1434 Basil G. Issa, Lorenz Becker, Kelly Cheer, Anne-Marie Kelly
36 [GO] 2020―Oct―20 Response to Comment on McIntyre and Moses The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic. Diabetes Care 2020;43:1433-1434 H. David McIntyre, Robert G. Moses
37 [GO] 2020―Oct―13 Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters Barrak Alahmad, Abdullah A. Al-Shammari, Abdullah Bennakhi, Fahd Al-Mulla, Hamad Ali
38 [GO] 2020―Oct―08 Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards Michael A. Nauck, Juris J. Meier
39 [GO] 2020―Oct―07 Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy Marco Mirani, Giuseppe Favacchio, Flaminia Carrone, Nazarena Betella, Emilia Biamonte, Emanuela Morenghi, et al. (+2)
40 [GO] 2020―Sep―29 Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study Sebastiano Bruno Solerte, Francesca D’Addio, Roberto Trevisan, Elisabetta Lovati, Antonio Rossi, Ida Pastore, et al. (+23)
41 [GO] 2020―Sep―26 The Impact of COVID-19 on CGM Use in the Hospital Nicole Ehrhardt, Irl B. Hirsch
42 [GO] 2020―Sep―22 Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407 Bertrand Cariou, Samy Hadjadj, Matthieu Wargny, Matthieu Pichelin, Pierre Gourdy
43 [GO] 2020―Sep―22 Response to Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407 Yuchen Chen, Dong Yang, Chen Yang, Ling Zheng, Kun Huang
44 [GO] 2020―Sep―22 Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398 Zebao He, Jie Li
45 [GO] 2020―Sep―22 Response to Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398 Qingxian Cai, Jun Chen, Lin Xu
46 [GO] 2020―Sep―05 COVID-19 and Children With Diabetes-Updates, Unknowns, and Next Steps: First, Do No Extrapolation Linda A. DiMeglio, Anastasia Albanese-O’Neill, Cynthia E. Muñoz, David M. Maahs
47 [GO] 2020―Aug―27 Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19 Jacqueline Seiglie, Jesse Platt, Sara Jane Cromer, Bridget Bunda, Andrea S. Foulkes, Ingrid V. Bassett, et al. (+7)
48 [GO] 2020―Aug―27 Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study Matthieu Wargny, Pierre Gourdy, Lisa Ludwig, Dominique Seret-Bégué, Olivier Bourron, Patrice Darmon, et al. (+7)
49 [GO] 2020―Aug―25 Metabolic Syndrome and COVID-19 Mortality Among Adult Black Patients in New Orleans John Xie, Yuanhao Zu, Ala Alkhatib, Thaidan T. Pham, Frances Gill, Albert Jang, et al. (+8)
50 [GO] 2020―Aug―21 Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany? Sascha René Tittel, Joachim Rosenbauer, Clemens Kamrath, Julian Ziegler, Felix Reschke, Johanna Hammersen, et al. (+4)
51 [GO] 2020―Aug―18 New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K. Rebecca Unsworth, Susan Wallace, Nick S. Oliver, Shunmay Yeung, Archana Kshirsagar, Harshini Naidu, et al. (+3)
52 [GO] 2020―Aug―12 Prevalence of Chronic Disease in Laboratory-Confirmed COVID-19 Cases and U.S. Adults (2017-2018) Michael Fang, Dan Wang, Olive Tang, Elizabeth Selvin
53 [GO] 2020―Aug―12 Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study Alberto Coppelli, Rosa Giannarelli, Michele Aragona, Giuseppe Penno, Marco Falcone, Giusy Tiseo, et al. (+6)
54 [GO] 2020―Aug―11 Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children? Ivana Rabbone, Riccardo Schiaffini, Valentino Cherubini, Claudio Maffeis, Andrea Scaramuzza
55 [GO] 2020―Aug―08 Characteristics and Diabetes Control in Adults With Type 1 Diabetes Admitted With COVID-19 Infection Maria Vamvini, Vasileios-Arsenios Lioutas, Roeland J.W. Middelbeek
56 [GO] 2020―Aug―08 The COVID-19 Outbreak Negatively Affects the Delivery of Care for Patients With Diabetic Foot Ulcers Chao Liu, Jiaxing You, Weifen Zhu, Yixin Chen, Shengyun Li, Yuefeng Zhu, et al. (+5)
57 [GO] 2020―Aug―08 Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience Sirimon Reutrakul, Matthew Genco, Harley Salinas, Robert M. Sargis, Carlie Paul, Yuval Eisenberg, et al. (+11)
58 [GO] 2020―Aug―08 Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019 Shivani Agarwal, Clyde Schechter, Will Southern, Jill P. Crandall, Yaron Tomer
59 [GO] 2020―Aug―05 Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis Matthew C. Riddle
60 [GO] 2020―Aug―04 Computed Tomography Highlights Increased Visceral Adiposity Associated With Critical Illness in COVID-19 Sofia Battisti, Claudio Pedone, Nicola Napoli, Emanuele Russo, Vanni Agnoletti, Stefano Geniere Nigra, et al. (+6)
61 [GO] 2020―Aug―04 Increased Hepatic ACE2 Expression in NAFL and Diabetes-A Risk for COVID-19 Patients? Jelena Soldo, Martin Heni, Alfred Königsrainer, Hans-Ulrich Häring, Andreas L. Birkenfeld, Andreas Peter
62 [GO] 2020―Jul―24 Diabetic Foot Problems During the COVID-19 Pandemic in a Tertiary Care Center: The Emergency Among the Emergencies Paola Caruso, Miriam Longo, Simona Signoriello, Maurizio Gicchino, Maria Ida Maiorino, Giuseppe Bellastella, et al. (+3)
63 [GO] 2020―Jul―10 No Evidence of Increased Hospitalization Rate for COVID-19 in Community-Dwelling Patients With Type 1 Diabetes Roman Vangoitsenhoven, Pieter-Jan Martens, Falco van Nes, Carolien Moyson, Frank Nobels, Paul Van Crombrugge, et al. (+5)
64 [GO] 2020―Jul―03 Renin-Angiotensin System Overactivation in Type 2 Diabetes: A Risk for SARS-CoV-2 Infection? Abu Saleh Md Moin, Ahmed Al-Qaissi, Thozhukat Sathyapalan, Stephen L. Atkin, Alexandra E. Butler
65 [GO] 2020―Jun―16 Diabetes Epidemiology in the COVID-19 Pandemic Elizabeth Selvin, Stephen P. Juraschek
66 [GO] 2020―Jun―16 Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes Brunella Capaldo, Giovanni Annuzzi, Annalisa Creanza, Clemente Giglio, Raffaele De Angelis, Roberta Lupoli, et al. (+4)
67 [GO] 2020―Jun―16 Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters Jamie Hartmann-Boyce, Elizabeth Morris, Clare Goyder, Jade Kinton, James Perring, David Nunan, et al. (+6)
68 [GO] 2020―Jun―12 Saving the Diabetic Foot During the COVID-19 Pandemic: A Tale of Two Cities Laura Shin, Frank L. Bowling, David G. Armstrong, Andrew J.M. Boulton
69 [GO] 2020―Jun―05 Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy Ernesto Maddaloni, Lucia Coraggio, Silvia Pieralice, Angela Carlone, Paolo Pozzilli, Raffaella Buzzetti
70 [GO] 2020―Jun―05 Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S. Osagie A. Ebekozien, Nudrat Noor, Mary Pat Gallagher, G. Todd Alonso
71 [GO] 2020―May―22 Early Observation and Mitigation of Challenges in Diabetes Management of COVID-19 Patients in Critical Care Units Osama Hamdy, Robert A. Gabbay
72 [GO] 2020―May―20 Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control? Celestino Sardu, Nunzia D’Onofrio, Maria Luisa Balestrieri, Michelangela Barbieri, Maria Rosaria Rizzo, Vincenzo Messina, et al. (+4)
73 [GO] 2020―May―20 Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits Shitao Rao, Alexandria Lau, Hon-Cheong So
74 [GO] 2020―May―14 Remote Glucose Monitoring of Hospitalized, Quarantined Patients With Diabetes and COVID-19 Gilat Shehav-Zaltzman, Gad Segal, Noa Konvalina, Amir Tirosh
75 [GO] 2020―May―14 Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era Antonio Ceriello, Eberhard Standl, Doina Catrinoiu, Baruch Itzhak, Nebojsa M. Lalic, Dario Rahelic, et al. (+3)
76 [GO] 2020―May―14 Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication Yuchen Chen, Dong Yang, Biao Cheng, Jian Chen, Anlin Peng, Chen Yang, et al. (+6)
77 [GO] 2020―May―14 COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports Matthew C. Riddle, John B. Buse, Paul W. Franks, William C. Knowler, Robert E. Ratner, Elizabeth Selvin, et al. (+2)
78 [GO] 2020―May―14 Opportunities for Research for COVID-19 in the Mission of NIDDK William T. Cefalu, Stephen P. James, Robert A. Star
79 [GO] 2020―May―14 The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic H. David McIntyre, Robert G. Moses
80 [GO] 2020―May―14 Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study Qiao Shi, Xiaoyi Zhang, Fang Jiang, Xuanzhe Zhang, Ning Hu, Chibu Bimu, et al. (+12)
81 [GO] 2020―May―14 Obesity Is a Risk Factor for Greater COVID-19 Severity Feng Gao, Kenneth I. Zheng, Xiao-Bo Wang, Qing-Feng Sun, Ke-Hua Pan, Ting-Yao Wang, et al. (+5)
82 [GO] 2020―May―14 Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China Qingxian Cai, Fengjuan Chen, Tao Wang, Fang Luo, Xiaohui Liu, Qikai Wu, et al. (+6)


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.018 sec